RIFABUTIN FORMULATION IN THE FORM OF LIPID NANOPARTICLES WHICH ARE POTENTIAL FOR ORAL ADMINISTRATION
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. The annual death number caused by tuberculosis is very large. The most common case is tuberculosis co-infection with HIV. Rifabutin is one of the drug taken for patients with this condition. Rifabutin has a few limitation...
Saved in:
Main Author: | Hidayat, Taufik |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/44115 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
FORMULASI DAN EVALUASI SOLID LIPID NANOPARTICLES (SLN) RIFABUTIN
by: Sandra Dewi, Marcellina -
Rifabutin Is active against mycobacterium abscessus complex
by: Aziz, D.B, et al.
Published: (2020) -
SOLID LIPID NANOPARTICLE DEVELOPMENT FORMULATION TRANSDERMAL DOSAGE FORM OF FUROSEMIDE AND IN VITRO TESTING
by: Forestryana, Dyera -
FORMULATION, CHARACTERIZATION, AND IN VITRO TOXICITY TEST OF LIPID NANOPARTICLE DOSAGE FORM FOR SIMVASTATIN DRUG DELIVERY
by: Ricardo Setiadi, Anfield -
Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration
by: Okonogi,S., et al.
Published: (2015)